Prior Biologic Use Tied to JAK Inhibitor Benefit in Ulcerative Colitis

(MedPage Today) — LAS VEGAS — Prior exposure to anti-tumor necrosis factor (TNF) therapy was associated with a lower risk of colectomy among patients receiving Janus kinase (JAK) inhibitor rescue therapy for acute severe ulcerative colitis…